Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07609810 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Palmitoylethanolamide in Ulcerative Colitis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Eligibility criteria shortened, about 19 words · Secondary endpoints: details revised at 1 of 6 entries · Site details revised · 1 more Show 4 more changesShow less
    • Eligibility criteria shortened, about 19 words
    • Secondary endpoints: details revised at 1 of 6 entries
    • Site details revised
    • Publications: details revised at 25 of 26 entries
  2. Start date: Jul 15, 2026 to Aug 15, 2026 Interventions: Palmitoylethanolamide (PEA) (Dietary Supplement) to Palmitoylethanolamide (PEA) (Dietary Supplement), Placebo (Other)v4 Show 1 more changeShow less
    • Interventions: Palmitoylethanolamide (PEA) (Dietary Supplement) to Palmitoylethanolamide (PEA) (Dietary Supplement), Placebo (Other)
  3. Site contact updatedv3
  4. Secondary endpoints: details revised at 3 of 6 entriesv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the effects of PEA supplementation on disease activity, health-related quality of life (HRQoL) and inflammatory biomarkers in patients with active mild-to-moderate UC.
Trial Details
NCT Number NCT07609810
Lead Sponsor Ain Shams University
Conditions Ulcerative Colitis (UC)
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov